Clinical Trial Update: The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy [Phase 3]

View source ↗

Summary

Phase 3 trial assessing lef lunomide or azathioprine therapy in myasthenia gravis patients after thymectomy; completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• Azathioprine (azathioprine)
• Leflunomide (Leflunomide)

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Myasthenia Gravis | Phase 3 | Status: COMPLETED